Form 4: Glaukos Corp Director Aimee Weisner Reports Stock Grant and Option Award
SEC Form 4 Filing
Director Aimee Weisner reported the acquisition of restricted stock units and stock options in Glaukos Corporation.
Summary
- Aimee Weisner, a director of Glaukos Corporation, filed a Form 4 detailing changes in beneficial ownership.
- On May 30, 2024, Weisner acquired 1,716 shares of common stock through a grant of restricted stock units, which will vest on the one-year anniversary of the grant date.
- Weisner also acquired a stock option to buy 1,246 shares of common stock at a price of $110.7, which vests in full on the one-year anniversary of the grant date and expires on May 30, 2034.
- Following these transactions, Weisner directly owns 1,246 derivative securities and 30,119 shares of common stock.
- Weisner also indirectly owns 15,000 shares through the Saeman-Weisner Family Trust and 2,000 shares through the Weisner Saeman Family Irrevocable Trust.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document simply reports routine transactions by a company director. It doesn't indicate any specific positive or negative outlook for the company.
Positives
- The grant of restricted stock units and stock options to a director aligns their interests with those of the shareholders.
- The vesting schedules encourage long-term commitment from the director.
Future Outlook
The restricted stock units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. The stock options vest in full on the one-year anniversary of the grant date and expire on May 30, 2034.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely monitored by investors to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash, stock options, and restricted stock units.
- Vesting schedules are typically structured to incentivize long-term performance and retention.
- The specific terms of the grant, such as the number of shares and the exercise price, are determined by the company's compensation committee and are benchmarked against industry peers.
Stakeholder Impact
- The transactions reported in the Form 4 filing may have a minor impact on shareholders by increasing the number of outstanding shares upon vesting of the restricted stock units.
- The stock option award provides an incentive for the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of transaction: grant of restricted stock units and stock option award. |
| 05/30/2025 | Vesting date for the restricted stock units and stock option award. |
| 05/30/2034 | Expiration date for the stock option award. |
| 06/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.